MENU
+Compare
AVIR
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$3.45
Change
-$0.08 (-2.27%)
Capitalization
295.25M

AVIR Atea Pharmaceuticals Forecast, Technical & Fundamental Analysis

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more

Industry: #Biotechnology
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AVIR with price predictions
Jun 27, 2025

Aroon Indicator for AVIR shows an upward move is likely

AVIR's Aroon Indicator triggered a bullish signal on June 27, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator showed a similar pattern. In of the 131 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 20, 2025. You may want to consider a long position or call options on AVIR as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AVIR moved above its 50-day moving average on May 23, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AVIR crossed bullishly above the 50-day moving average on June 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVIR advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

AVIR broke above its upper Bollinger Band on June 23, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.718) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). AVIR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVIR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
AVIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AVIR is expected to report earnings to rise 6.67% to -42 cents per share on August 06

Atea Pharmaceuticals AVIR Stock Earnings Reports
Q2'25
Est.
$-0.43
Q1'25
Beat
by $0.01
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.18
The last earnings report on May 12 showed earnings per share of -40 cents, beating the estimate of -40 cents. With 444.47K shares outstanding, the current market capitalization sits at 295.25M.
A.I. Advisor
published General Information

General Information

a developer of vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Franklin Street
Phone
+1 857 284-8891
Employees
75
Web
https://www.ateapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSUMF10.050.22
+2.24%
FORTESCUE LTD.
INPOY8.310.01
+0.18%
InPost S A
ECIA0.37N/A
N/A
Encision, Inc.
ALGEF0.02N/A
N/A
ALLIGATOR ENERGY LTD.
BDGIF34.52-0.37
-1.06%
Badger Infrastructure Solutions Ltd

AVIR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AVIR has been loosely correlated with IMNM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVIR jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVIR
1D Price
Change %
AVIR100%
-2.27%
IMNM - AVIR
47%
Loosely correlated
-0.23%
XENE - AVIR
46%
Loosely correlated
+0.62%
MGTX - AVIR
45%
Loosely correlated
-0.90%
FHTX - AVIR
43%
Loosely correlated
-0.41%
VNDA - AVIR
43%
Loosely correlated
-0.83%
More